Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Wu, Long ^a   Peng, Chun Wei ^a   Hou, Jin Xuan ^a   Zhang, Yan Hua ^a   Chen, Chuang ^a   Chen, Liang Dong ^a   Li, Yan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORONIN 1C PROTEIN; KHELLIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CORONIN PROTEINS; TUMOR MARKER;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; WESTERN BLOTTING; ADOLESCENT; ANIMAL; BAGG ALBINO MOUSE; EVALUATION; LIVER TUMOR; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; TUMOR CELL LINE;

ADOLESCENT; ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950245981     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-17     Document Type: Article

References (40)

1. Global Cancer Statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. Mouse Models to Study the Interaction of Risk Factors for Human Liver Cancer. S Sell, Cancer Res 2003 63 7553 7562 14633666
3. A decade's studies on metastasis of hepatocellular carcinoma. ZY Tang SL Ye YK Liu LX Qin HC Sun QH Ye L Wang J Zhou SJ Qiu Y Li XN Ji H Liu JL Xia ZQ Wu J Fan ZC Ma XD Zhou ZY Lin KD Liu, J Cancer Res Clin Oncol 2004 130 187 196 10.1007/s00432-003-0511-1 14685850
4. Hepatocellular carcinoma: recent trends in the United States. HB El Serag, Gastroenterology 2004 127 5 Suppl 1 27 S34 10.1053/j.gastro.2004.09.013 15508094
5. Hepatocellular carcinoma. JM Llovet A Burroughs J Bruix, Lancet 2003 362 1907 1917 10.1016/S0140-6736(03)14964-1 14667750
6. Experimental models of hepatocellular carcinoma: developments and evolution. L Wu ZY Tang Y Li, J Cancer Res Clin Oncol 2009 135 969 981 10.1007/s00432-009-0591-7 19399516
7. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. M Kudo, Oncology 2008 75 Suppl 1 1 12 10.1159/000181865 19092266
8. Novel advancements in the management of hepatocellular carcinoma in 2008. JM Llovet J Bruix, J Hepatol 2008 48 20 S37 10.1016/j.jhep.2008.01.022 18304676
9. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. LX Qin ZY Tang, J Cancer Res Clin Oncol 2004 130 497 513 10.1007/s00432-004-0572-9 15205947
10. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. J Tian ZY Tang SL Ye YK Liu ZY Lin J Chen Q Xue, Br J Cancer 1999 81 814 821 10.1038/sj.bjc.6690769 10555751
11. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. Y Li Y Tang L Ye YK Liu J Chen Q Xue J Chen DM Gao WH Bao, World J Gastroenterol 2001 7 630 636 11819844
12. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. Y Li Y Tang L Ye B Liu K Liu J Chen Q Xue, J Cancer Res Clin Oncol 2003 129 43 51 10.1007/s00432-003-0493-z 12618900
13. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. Y Li B Tian J Yang L Zhao X Wu SL Ye YK Liu ZY Tang, J Cancer Res Clin Oncol 2004 130 460 468 10.1007/s00432-004-0564-9 15146329
14. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients. Y Li ZY Tang B Tian SL Ye LX Qin Q Xue RX Sun, J Cancer Res Clin Oncol 2006 132 515 520 10.1007/s00432-006-0098- 4 16788845
15. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. SJ Ding Y Li YX Tan MR Jiang B Tian YK Liu XX Shao SL YE JR Wu R Zeng HY Wang ZY Tang QC Xia, Mol Cell Proteomics 2004 3 73 81 14593079
16. Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention. A Albini, Cancer Metastasis Rev 2008 27 3 4 10.1007/s10555-007-9102-y 18043872
17. Cell motility through plasma membrane blebbing. OT Fackler R Grosse, J Cell Biol 2008 181 879 884 10.1083/jcb.200802081 18541702
18. Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits. EL de Hostos B Bradtke F Lottspeich R Guggenheim G Gerisch, EMBO J 1991 10 4097 4104 1661669
19. Coronins: the return of the crown. AC Uetrecht JE Bear, Trends Cell Biol 2006 16 421 426 10.1016/j.tcb.2006.06.002 16806932
20. Production of embryonal alpha-globulin by transplantable mouse hepatomas. GI Abelev SD Perova NI Khramkova ZA Postnikova IS Irlin, Transplantation 1963 1 174 180 14010646
21. Afp-l3: a new generation of tumor marker for hepatocellular carcinoma. D Li T Mallory S Satomura, Clin Chim Acta 2001 313 15 19 10.1016/S0009-8981(01) 00644-1 11694234
22. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. IC Weitz HA Liebman, Hepatology 1993 18 990 997 10.1002/hep.1840180434 8406374
23. Serum alpha-l-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma? Y Deugnier V David P Brissot P Mabo D Delamaire M Messner, Hepatology 1984 4 889 892 10.1002/hep.1840040516 6207091
24. Cloning and Expression of a Developmentally Regulated Transcript MXR7 in Hepatocellular Carcinoma: Biological Significance and Temporospatial Distribution. HC Hsu W Cheng PL Lai, Cancer Res 1997 57 5179 5184 9371521
25. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. N Ito S Kawata S Tamura K Takaishi Y Shirai S Kiso, Cancer Res 1991 51 4080 4083 1649698
26. Differential Expression of Insulin-like Growth Factor II mRNA in Human Primary Liver Cancers, Benign Liver Tumors, and Liver Cirrhosis. E Cariani C Lasserre D Seurin B Hamelin F Kemeny D Franco, Cancer Res 1988 48 6844 6849 3180092
27. Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma. MB Ranke KP Maier R Schweizer B Stadler S Schleicher MW Elmlinger, Horm Res 2003 60 174 180 10.1159/000073229 14530605
28. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma. SK Yoon NK Lim SA Ha YG Park JY Choi KW Chung, Cancer Res 2004 64 5434 5441 10.1158/0008-5472.CAN-03-3665 15289352
29. Gp73, a resident golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. JA Marrero PR Romano O Nikolaeva L Steel A Mehta CJ Fimmel, J Hepatol 2005 43 1007 1012 10.1016/j.jhep.2005.05.028 16137783
30. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in c-viral chronic liver diseases. H Yamagamim M Moriyama H Matsumura H Aoki T Shimizu T Saito, Cancer 2002 95 824 834 10.1002/cncr.10732 12209727
31. Detection of serum and intrahepatic KL-6 in anti-HCV positive patients with hepatocellular carcinoma. M Moriyama H Matsumura A Watanabe H Nakamura Y Arakawa S Oshiro, Hepatol Res 2004 30 24 33 10.1016/j.hepres.2004.04.007 15341771
32. Angiogenesis and hepatocellular carcinoma. D Semela JF Dufour, J Hepatol 2004 41 864 880 10.1016/j.jhep.2004.09.006 15519663
33. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma. HW Hann J Lee A Bussard C Liu YR Jin K Guha, Cancer Res 2004 64 7329 7335 10.1158/0008-5472.CAN-04-1095 15492253
34. The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer. WQ Hu CW Peng Y Li, J Exp Clin Cancer Res 2009 28 144 150 10.1186/1756-9966-28-144 19930704
35. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma. W Li E Gomez Z Zhang, J Exp Clin Cancer Res 2007 26 527 533 18365549
36. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues. N Li Y Long X Fan H Liu C Li L Chen Z Wang, J Exp Clin Cancer Res 2009 28 122 132 10.1186/1756-9966-28-122 19715608
37. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. FM Qiu JK Yu YD Chen QF Jin MH Sui J Huang, J Exp Clin Cancer Res 2009 28 126 133 10.1186/1756-9966-28-126 19740432
38. Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking. V Rybakin CS Clemen, Bioessays 2005 27 625 632 10.1002/bies.20235 15892111
39. Oligomerization, F-actin interaction, and membrane association of the ubiquitous mammalian coronin 3 are mediated by its carboxyl terminus. Z Spoerl M Stumpf AA Noegel A Hasse, J Biol Chem 2002 277 48858 48867 10.1074/jbc. M205136200 12377779
40. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. D Thal CP Xavier A Rosentreter S Linder B Friedrichs A Waha T Pietsch M Stumpf A Noegel C Clemen, J Pathol 2008 214 415 424 10.1002/path.2308 18189330